Facial Papules in Frontal Fibrosing Alopecia (FFA)

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT07340671
Status
Recruiting
Apply to this trial

Conditions

  • Frontal Fibrosing Alopecia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cutera® 1726 nm laser system — DEVICE
    Participants will receive 3 laser treatments at 4 (±1) week intervals and will be followed at approximately at 12 (± 2) weeks post treatment completion onsite.

Study Details

The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of facial papules in frontal fibrosing alopecia (FFA).

Key Dates

First listed
Jan 14, 2026
Start date
Apr 28, 2026
Status verified
Apr 2026
Primary completion
Apr 26, 2027
Completion
Apr 28, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 1726 nm Laser Treatment Group
    Participants will be in this group for up to approximately 30 weeks and complete up to 5 visits

Primary Outcome Measure

Change in lesion size (papule diameter in mm) measured by dermatoscope and ultrasound [ Time Frame: Baseline periprocedural and through study completion (an average of 30 weeks) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MiamiMiamiFlorida33136
Ariel Eber, MD

Find similar trials in Miami, FL

By research site
University of Miami· Miami, FL

Related Studies